Hepatitis C virus and carpal tunnel syndrome in hemodialysis patients: a single center cross-sectional study

References

• Drüeke TB. Beta2-microglobulin and amyloidosis. Nephrol Dial Transplant. 2000;15(suppl_1):17–24.
   PubMedGoogle Scholar
• Jadoul M, Drüeke TB. β2 microglobulin amyloidosis: an update 30 years later. Nephrol Dial Transplant. 2016;31(4):507–509.
   PubMed Web of Science ®Google Scholar
• Weng CH, Hu CC, Yen TH, et al. Association between environmental particulate matter and carpal tunnel syndrome in patients undergoing hemodialysis. Kidney Blood Press Res. 2017;42(5):827–836.
   PubMed Web of Science ®Google Scholar
• Kopeć J, Gadek A, Drozdz M, et al. Carpal tunnel syndrome in hemodialysis patients as a dialysis-related amyloidosis manifestation–incidence, risk factors and results of surgical treatment. Med Sci Monit. 2011;17(9):CR505–R509.
   PubMed Web of Science ®Google Scholar
• Hoshino J, Yamagata K, Nishi S, et al. Carpal tunnel surgery as proxy for dialysis-related amyloidosis: results from the Japanese society for dialysis therapy. Am J Nephrol. 2014;39(5):449–458.
   PubMed Web of Science ®Google Scholar
• Busch M, Schwenzky A, Franke S, et al. Advanced glycation end products and β(2)-microglobulin as predictors of carpal tunnel syndrome in hemodialysis patients. Blood Purif. 2012;34(1):3–9.
   PubMed Web of Science ®Google Scholar
• Jadoul M, Bieber BA, Martin P, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int. 2019;95(4):939–947.
   PubMed Web of Science ®Google Scholar
• Roth D, Bloom RD, Molnar MZ, et al. KDOQI US commentary on the 2018 KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C. Am J Kidney Dis. 2020;75(5):665–683.
   PubMed Web of Science ®Google Scholar
• Takeda H, Takai A, Inuzuka T, et al. Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis. J Gastroenterol. 2017;52(1):26–38.
   PubMed Web of Science ®Google Scholar
• de Mochel NS, Seronello S, Wang SH, et al. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology. 2010;52(1):47–59.
   PubMed Web of Science ®Google Scholar
• Machida K, McNamara G, Cheng KT, et al. Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. J Immunol. 2010;185(11):6985–6998.
   PubMed Web of Science ®Google Scholar
• Pal S, Polyak SJ, Bano N, et al. Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. J Gastroenterol Hepatol. 2010;25(3):627–634.
   PubMed Web of Science ®Google Scholar
• Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, et al. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J Hepatol. 2009;50(5):872–882.
   PubMed Web of Science ®Google Scholar
• Irshad M, Mankotia DS, Irshad K. An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol. 2013;19(44):7896–7909.
   PubMed Web of Science ®Google Scholar
• Huang WH, Hsu CW, Weng CH, et al. Association of a high normalized protein catabolic rate and low serum albumin level with carpal tunnel syndrome in hemodialysis patients. Medicine (Baltimore). 2016;95(26):e4050.
   PubMed Web of Science ®Google Scholar
• Oyake N, Shimada T, Murakami Y, et al. Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients. J Nephrol. 2008;21(3):345–353.
   PubMed Web of Science ®Google Scholar
• Klauser AS, Halpern EJ, De Zordo T, et al. Carpal tunnel syndrome assessment with US: value of additional cross-sectional area measurements of the median nerve in patients versus healthy volunteers. Radiology. 2009;250(1):171–177.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Kawahara N, Arai K, et al. Utility of ultrasonography of the median nerve with a high-frequency probe for the diagnosis of dialysis-related carpal tunnel syndrome. Ther Apher Dial. 2016;20(5):483–491.
   PubMed Web of Science ®Google Scholar
• Rahnavardi M, Hosseini MS, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol. 2008;28(4):628–640.
   PubMed Web of Science ®Google Scholar
• Sułowicz W, Radziszewski A, Chowaniec E. Hepatitis C virus infection in dialysis patients. Hemodial Int. 2007;11(3):286–295.
   PubMedGoogle Scholar
• Dung NH, Loc ND, Quyen DBQ, et al. Association between low serum prealbumin levels and carpal tunnel syndrome in maintenance hemodialysis patients. Ren Fail. 2020;42(1):944–949.
   PubMed Web of Science ®Google Scholar
• Padua L, Coraci D, Erra C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016;15(12):1273–1284.
   PubMed Web of Science ®Google Scholar
• Genova A, Dix O, Saefan A, et al. Carpal tunnel syndrome: a review of literature. Cureus. 2020;12(3):e7333
   PubMed Web of Science ®Google Scholar
• Jadoul M, Garbar C, Noël H, et al. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int. 1997;51(6):1928–1932.
   PubMed Web of Science ®Google Scholar
• Liabeuf S, Lenglet A, Desjardins L, et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney Int. 2012;82(12):1297–1303.
   PubMed Web of Science ®Google Scholar
• Drueke TB, Massy ZA. Beta2-microglobulin. Semin Dial. 2009;22(4):378–380.
   PubMed Web of Science ®Google Scholar
• Scarpioni R, Ricardi M, Albertazzi V, et al. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis. 2016;9:319–328.
   PubMed Web of Science ®Google Scholar
• Zumrutdal A. Role of β2-microglobulin in uremic patients may be greater than originally suspected. World J Nephrol. 2015;4(1):98–104.
   PubMedGoogle Scholar
• Labriola L, Jadoul M. Dialysis-related amyloidosis: is it gone or should it be? Semin Dial. 2017;30(3):193–196.
   PubMed Web of Science ®Google Scholar
• Hoshino J, Yamagata K, Nishi S, et al. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010. Nephrol Dial Transplant. 2016;31(4):595–602.
   PubMed Web of Science ®Google Scholar
• Schiffl H. Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients. Hemodial Int. 2014;18(1):136–141.
   PubMed Web of Science ®Google Scholar
• Huang WH, Hu CC, Yen TH, et al. Blood lead level: an overlooked risk of carpal tunnel syndrome in hemodialysis patients. Ren Fail. 2019;41(1):786–793.
   PubMed Web of Science ®Google Scholar
• Timofte D, Dragos D, Balcangiu-Stroescu AE, et al. Infection with hepatitis C virus in hemodialysis patients: an overview of the diagnosis and prevention rules within a hemodialysis center (review). Exp Ther Med. 2020;20(1):109–116.
   PubMed Web of Science ®Google Scholar
• Inoue H, Saito I, Nakazawa R, et al. Expression of inflammatory cytokines and adhesion molecules in haemodialysis-associated amyloidosis. Nephrol Dial Transplant. 1995;10(11):2077–2082.
   PubMed Web of Science ®Google Scholar
• Ohno T, Tanaka Y, Sugauchi F, et al. Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis. Hepatol Res. 2008;38(7):683–688.
   PubMed Web of Science ®Google Scholar
• Waris G, Turkson J, Hassanein T, et al. Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol. 2005;79(3):1569–1580.
   PubMed Web of Science ®Google Scholar
• Machida K, Cheng KT, Sung VM, et al. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol. 2004;78(16):8835–8843.
   PubMed Web of Science ®Google Scholar
• Gong G, Waris G, Tanveer R, et al. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA. 2001;98(17):9599–9604.
   PubMed Web of Science ®Google Scholar
• Smirnova OA, Ivanova ON, Bartosch B, et al. Hepatitis C virus NS5A protein triggers oxidative stress by inducing NADPH oxidases 1 and 4 and cytochrome P450 2E1. Oxid Med Cell Longev. 2016;2016:8341937
   PubMed Web of Science ®Google Scholar
• de Almeida JP, Liberatti LS, Barros FE, et al. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C. Nutrition. 2016;32(3):362–367.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304–1313.
   PubMed Web of Science ®Google Scholar